Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3108879 19 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Paraproteinaemic neuropathies are a heterogeneous group of disorders most frequently associated with IgM monoclonal gammopathies including Waldenström macroglobulinaemia (WM). Their consequences are significant for affected patients, and their management challenging for their physicians. The variability in clinical presentation and time course hamper classification and management. The indications for invasive investigations such as cerebrospinal fluid analysis, nerve conduction tests and sensory nerve biopsies are unclear, and the optimum way to measure clinical response to treatment unknown. When to intervene and and how to treat, also present challenges to physicians. As part of its latest deliberations at the International Workshops on WM (IWWM) in London, UK (August 2014), the IWWM8 panel have proposed a consensus approach to the diagnosis and management of peripheral neuropathies associated with IgM monoclonal gammopathies, including WM. Importantly, a consensus regarding the use of clinical outcome measures and recommended models of care for this group of patients is discussed, as well as appropriate treatment interventions. © 2017 John Wiley & Sons Ltd
Έτος δημοσίευσης:
2017
Συγγραφείς:
D'Sa, S.
Kersten, M.J.
Castillo, J.J.
Dimopoulos, M.
Kastritis, E.
Laane, E.
Leblond, V.
Merlini, G.
Treon, S.P.
Vos, J.M.
Lunn, M.P.
Περιοδικό:
British Journal of Haematology
Εκδότης:
Wiley-Blackwell Publishing Ltd
Τόμος:
176
Αριθμός / τεύχος:
5
Σελίδες:
728-742
Λέξεις-κλειδιά:
alkylating agent; barbituric acid derivative; bortezomib; botulinum toxin; carfilzomib; clonazepam; corticosteroid; cyclophosphamide; dexamethasone; gabapentin; ibrutinib; immunoglobulin; immunoglobulin M; ixazomib; prednisolone; propranolol; purine derivative; rituximab; topiramate; tricyclic antidepressant agent; immunoglobulin M, amyloidosis; Article; ataxia; cerebrospinal fluid examination; computer assisted tomography; echography; electromyography; human; nerve biopsy; nerve conduction; nuclear magnetic resonance imaging; ophthalmoplegia; peripheral neuropathy; phenotype; plasma exchange; skin biopsy; small fiber neuropathy; Waldenstroem macroglobulinemia; Paraproteinemias; Peripheral Nervous System Diseases; practice guideline; Waldenstrom Macroglobulinemia, Humans; Immunoglobulin M; Paraproteinemias; Peripheral Nervous System Diseases; Waldenstrom Macroglobulinemia
Επίσημο URL (Εκδότης):
DOI:
10.1111/bjh.14492
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.